Fieldpoint Private Securities, LLC Bristol Myers Squibb CO Transaction History

Fieldpoint Private Securities, LLC

$344 Million
Q2 2022

A detailed history of Fieldpoint Private Securities, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 4,428 shares of BMY stock, worth $225,473. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,428

Previous 6,441 31.25%

Holding current value

$225,473

Previous $470,000 27.45%

% of portfolio

0.1%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $146,184 - $160,999	-2,013 Reduced 31.25%	4,428 $341,000
Q1 2022 Apr 07, 2022	BUY	$61.48 - $73.72 $11,558 - $13,859	188 Added 3.01%	6,441 $470,000
Q4 2021 Jan 24, 2022	SELL	$53.63 - $62.52 $70,523 - $82,213	-1,315 Reduced 17.38%	6,253 $390,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $7,751 - $9,079	-131 Reduced 1.7%	7,568 $448,000
Q2 2021 Aug 12, 2021	BUY	$61.91 - $67.42 $95,589 - $104,096	1,544 Added 25.09%	7,699 $519,000
Q1 2021 Apr 23, 2021	SELL	$59.34 - $66.74 $81,651 - $91,834	-1,376 Reduced 18.27%	6,155 $389,000
Q4 2020 Jan 28, 2021	BUY	$57.74 - $65.43 $142,906 - $161,939	2,475 Added 48.95%	7,531 $467,000
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $31,988 - $35,447	557 Added 12.38%	5,056 $305,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $37,716 - $44,093	688 Added 18.05%	4,499 $265,000
Q1 2020 May 11, 2020	SELL	$46.4 - $67.43 $5,289 - $7,687	-114 Reduced 2.9%	3,811 $212,000
Q4 2019 Feb 10, 2020	SELL	$49.21 - $64.19 $4,773 - $6,226	-97 Reduced 2.41%	3,925 $252,000
Q3 2019 Nov 07, 2019	SELL	$42.77 - $50.71 $7,142 - $8,468	-167 Reduced 3.99%	4,022 $204,000
Q2 2019 Aug 14, 2019	SELL	$44.62 - $49.34 $435,982 - $482,101	-9,771 Reduced 69.99%	4,189 $190,000
Q1 2019 May 13, 2019	BUY	$45.12 - $53.8 $15,295 - $18,238	339 Added 2.49%	13,960 $666,000
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $43,835 - $56,843	-899 Reduced 6.19%	13,621 $708,000
Q3 2018 Nov 15, 2018	BUY	$55.19 - $62.25 $49,726 - $56,087	901 Added 6.62%	14,520 $901,000
Q2 2018 Aug 06, 2018	SELL	$50.53 - $62.98 $71,550 - $89,179	-1,416 Reduced 9.42%	13,619 $754,000
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $25,825 - $29,730	431 Added 2.95%	15,035 $951,000
Q4 2017 Feb 15, 2018	SELL	$59.94 - $65.35 $29,850 - $32,544	-498 Reduced 3.3%	14,604 $895,000
Q3 2017 Nov 15, 2017	BUY	$55.23 - $63.74 $834,083 - $962,601	15,102	15,102 $963,000

Others Institutions Holding BMY

# of Institutions

2,400

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $108B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fieldpoint Private Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fieldpoint Private Securities, LLC with notifications on news.

Account

Fieldpoint Private Securities, LLC Bristol Myers Squibb CO Transaction History